Fortuna Haviv

918 total citations
24 papers, 620 citations indexed

About

Fortuna Haviv is a scholar working on Organic Chemistry, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Fortuna Haviv has authored 24 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 8 papers in Molecular Biology and 5 papers in Reproductive Medicine. Recurrent topics in Fortuna Haviv's work include Synthesis and biological activity (5 papers), Hypothalamic control of reproductive hormones (5 papers) and Synthesis and Biological Evaluation (4 papers). Fortuna Haviv is often cited by papers focused on Synthesis and biological activity (5 papers), Hypothalamic control of reproductive hormones (5 papers) and Synthesis and Biological Evaluation (4 papers). Fortuna Haviv collaborates with scholars based in United States, United Kingdom and Israel. Fortuna Haviv's co-authors include George W. Carter, James D. Ratajczyk, Eugene N. Bush, Patrick Young, Jack Henkin, Gilbert Diaz, James H. Holms, Francis A. J. Kerdesky, Jonathan Greer and Olga V. Volpert and has published in prestigious journals such as Journal of the American Chemical Society, Clinical Cancer Research and Endocrinology.

In The Last Decade

Fortuna Haviv

22 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fortuna Haviv United States 13 331 236 72 68 59 24 620
Mary Pat Beavers United States 17 408 1.2× 192 0.8× 63 0.9× 51 0.8× 25 0.4× 25 729
Philip N. Edwards United Kingdom 15 262 0.8× 239 1.0× 60 0.8× 16 0.2× 73 1.2× 25 588
John Porter United Kingdom 19 548 1.7× 241 1.0× 213 3.0× 145 2.1× 64 1.1× 38 1.1k
Jerry R. Brooks United States 6 399 1.2× 249 1.1× 30 0.4× 30 0.4× 87 1.5× 8 679
Hanyong Jin South Korea 15 411 1.2× 77 0.3× 65 0.9× 45 0.7× 48 0.8× 36 734
Howard Tucker United Kingdom 11 158 0.5× 111 0.5× 68 0.9× 21 0.3× 108 1.8× 19 509
Warren S. Wade United States 15 788 2.4× 246 1.0× 166 2.3× 67 1.0× 50 0.8× 24 1.1k
Ayumu Niida Japan 16 580 1.8× 293 1.2× 134 1.9× 187 2.8× 24 0.4× 27 867
Federico Medda United States 14 242 0.7× 300 1.3× 50 0.7× 22 0.3× 41 0.7× 21 613
Gene K. Yee United States 8 383 1.2× 76 0.3× 171 2.4× 9 0.1× 24 0.4× 12 706

Countries citing papers authored by Fortuna Haviv

Since Specialization
Citations

This map shows the geographic impact of Fortuna Haviv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fortuna Haviv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fortuna Haviv more than expected).

Fields of papers citing papers by Fortuna Haviv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fortuna Haviv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fortuna Haviv. The network helps show where Fortuna Haviv may publish in the future.

Co-authorship network of co-authors of Fortuna Haviv

This figure shows the co-authorship network connecting the top 25 collaborators of Fortuna Haviv. A scholar is included among the top collaborators of Fortuna Haviv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fortuna Haviv. Fortuna Haviv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janovick, Jo Ann, Shaun P. Brothers, Anda Cornea, et al.. (2007). Refolding of misfolded mutant GPCR: Post-translational pharmacoperone action in vitro. Molecular and Cellular Endocrinology. 272(1-2). 77–85. 40 indexed citations
2.
Rusk, Anthony, et al.. (2006). Preclinical Evaluation of Antiangiogenic Thrombospondin-1 Peptide Mimetics, ABT-526 and ABT-510, in Companion Dogs with Naturally Occurring Cancers. Clinical Cancer Research. 12(24). 7444–7455. 54 indexed citations
3.
Haviv, Fortuna, Eugene N. Bush, Judith Knittle, & Jonathan Greer. (2006). LHRH Antagonists. Kluwer Academic Publishers eBooks. 11. 131–149. 5 indexed citations
4.
Randolph, John T., Daryl R. Sauer, Fortuna Haviv, Angela M. Nilius, & Jonathan Greer. (2004). Elimination of antibacterial activities of non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists derived from erythromycin A. Bioorganic & Medicinal Chemistry Letters. 14(6). 1599–1602. 9 indexed citations
5.
Reiher, Frank, Olga V. Volpert, Benilde Jiménez, et al.. (2002). Inhibition of tumor growth by systemic treatment with thrombospondin‐1 peptide mimetics. International Journal of Cancer. 98(5). 682–689. 106 indexed citations
6.
Besecke, Leslie M., Gilbert Diaz, Jason A. Segreti, et al.. (2001). Pharmacological and endocrine characterization of A‐198401, an orally active GnRH antagonist, in intact and castrate male rat models. Drug Development Research. 52(3). 485–491. 14 indexed citations
7.
Haviv, Fortuna, Eugene N. Bush, Gilbert Diaz, et al.. (1994). In vitro and in vivo Activities of Reduced-Size Antagonists of Luteinizing Hormone-Releasing Hormone. Journal of Medicinal Chemistry. 37(5). 701–705. 6 indexed citations
8.
Janovick, Jo Ann, et al.. (1993). Differential orientation of a GnRH agonist and antagonist in the pituitary GnRH receptor.. Endocrinology. 133(2). 942–945. 16 indexed citations
9.
Haviv, Fortuna, et al.. (1993). Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists. Journal of Medicinal Chemistry. 36(3). 363–369. 75 indexed citations
10.
Adjei, Akwete, Sharon Love, E. S. Johnson, et al.. (1993). Effect of Formulation Adjuvants on Gastrointestinal Absorption of Leuprolide Acetate. Journal of drug targeting. 1(3). 251–258. 16 indexed citations
11.
Haviv, Fortuna, et al.. (1993). The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonists. Journal of Medicinal Chemistry. 36(7). 928–933. 16 indexed citations
12.
Kim, Ki Hwan, et al.. (1990). Quantitative Structure–Activity Relationships of Inhibitors of Immune Cornplex-Induced Inflammation: 1-Phenyl-3-aminopyrazoline Derivatives. Journal of Pharmaceutical Sciences. 79(7). 609–613. 3 indexed citations
13.
Kim, Ki H., Yvonne C. Martin, Patrick Young, George W. Carter, & Fortuna Haviv. (1990). Inhibitors of Immune Complex-Induced Inflammation: 5-Substituted 3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile Derivatives. Journal of Pharmaceutical Sciences. 79(8). 682–684.
14.
Kim, Ki Hwan, Yvonne C. Martin, Barbara J. Norris, & Fortuna Haviv. (1989). Inhibitors of Immune Complex-Induced Inflammation: 3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile Derivatives. Journal of Pharmaceutical Sciences. 78(6). 494–498. 1 indexed citations
15.
Haviv, Fortuna, Eugene N. Bush, Gilbert Diaz, et al.. (1989). Active reduced-size hexapeptide analogs of luteinizing hormone-releasing hormone. Journal of Medicinal Chemistry. 32(10). 2340–2344. 12 indexed citations
16.
Haviv, Fortuna, James D. Ratajczyk, Francis A. J. Kerdesky, et al.. (1988). 3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation. Journal of Medicinal Chemistry. 31(9). 1719–1728. 145 indexed citations
17.
Haviv, Fortuna, et al.. (1983). 2-[(Phenylthio)methyl]pyridine derivatives: new antiinflammatory agents. Journal of Medicinal Chemistry. 26(2). 218–222. 33 indexed citations
18.
Haviv, Fortuna & B. Belleau. (1978). Cyclitol analogs of biological interest. Regioselective nucleophilic substitutions of 1,4-cyclohexadiene bisepoxide and bisepisulfide. Canadian Journal of Chemistry. 56(20). 2677–2680. 7 indexed citations
19.
Wenkert, Ernest, Peter Bakuzis, & Fortuna Haviv. (1970). Transformations of 1-methyl-1-(dichloromethyl)cyclohexane derivatives. The Journal of Organic Chemistry. 35(6). 2092–2095.
20.
Wenkert, Ernest, et al.. (1969). Condensations of 4-methyl-4-dichloromethyl-2,5-cyclohexadienone. Journal of the American Chemical Society. 91(9). 2299–2307. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Pat Beavers Breakdown of academic impact, for papers by Philip N. Edwards Breakdown of academic impact, for papers by John Porter Breakdown of academic impact, for papers by Jerry R. Brooks Breakdown of academic impact, for papers by Hanyong Jin Breakdown of academic impact, for papers by Howard Tucker Breakdown of academic impact, for papers by Warren S. Wade Breakdown of academic impact, for papers by Ayumu Niida Breakdown of academic impact, for papers by Federico Medda Breakdown of academic impact, for papers by Gene K. Yee
Rankless by CCL
2026